is glp-3 retatrutide Comment “Curious” for the deep dive. — a.k.a. “Reta” or “GLP-3” — being called a future “trillion-dollar drug” and a revolution in fat loss. Retatrutide is a third-generation GLP-1–based drug. ( GLP-3 (Reta) 10mg | Purity

New England Journal of Medicine: Retatrutide Phase 2 trial results - The landmark study establishing retatrutide efficacy and safety across multiple dose groups New England Journal of Medicine: STEP 1 semaglutide trial results - The pivotal trial demonstrating semaglutide 2.4 mg weight loss efficacy ClinicalTrials.gov: Retatrutide TRIUMPH program - Current status and details of all ongoing Phase 3 retatrutide trials FDA prescribing information for Wegovy (semaglutide 2.4 mg) - Complete approved labeling including dosing, safety, and clinical data New England Journal of Medicine: SELECT cardiovascular outcomes trial - The trial demonstrating semaglutide 20% reduction in major cardiovascular events These primary sources should be the foundation for any serious evaluation of either compound

Langeskov EK, Kristensen K

Every batch is tested for purity and potency in ISO-certified facilities

A 5 mg dose on the same vial is 10 units

Sus funciones son cruciales para el metabolismo: "mejora la secrecin de insulina , ralentiza la digestin y suprime el apetito", explica Sainz